CytoDyn Inc (OTCMKTS:CYDY) has seen a spectacular rise in recent months from well under $0.50 back in December to recent highs of $3.50 per share. The...
CytoDyn Inc (OTCMKTS:CYDY) has been getting increased attention after the Company took its leronlimab to the front lines against the deadly coronavirus “COVID-19” pandemic. On March...
CytoDyn Inc (OTCMKTS:CYDY) got another boost after the Company said it filed an IND and protocol for phase 2 clinical trial for treatment of the coronavirus...
CytoDyn Inc (OTCMKTS:CYDY) went into full beast mode starting in December off its $0.25 base running to highs of $1.68 in February before suffering a significant...
CytoDyn Inc (OTCMKTS:CYDY) recently saw a significant move up the charts from under $0.30 in December to highs of $1.65 per share. Since than it has...
CytoDyn Inc (OTCMKTS:CYDY) has established a new base over the $1 mark in recent trading and speculators are looking for another leg up. CYDY popped to...
